Sun Pharmaceutical Industries is to announce its first quarter results. According to CNBC-TV18's estimates, the company's Q1FY12 revenues are seen up 22% to Rs 1709 crore versus Rs 1400 crore, year-on-year, YoY.
Its EBITDA is seen down 13% at Rs 524 crore versus Rs 600 crore.
Its OPM is seen 30.7% versus 43%.
The company's PAT is seen down 13% to Rs 489 crore versus Rs 564 crore, YoY.
Q1FY12 QoQ
The company Q1FY12 revenues are seen 17% to Rs 1709 crore versus Rs 1463 crore, quarter-on-quarter, QoQ.
Its EBITDA is seen up 18% to Rs 524 crore versus Rs 444 crore, QoQ
Its OPM is seen 30.7% versus 30.3%.
The company's PAT is seen up 10% to Rs 489 crore versus Rs 443 crore, QoQ
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
